These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38598827)

  • 21. Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy.
    Leapman MS; Thiel CL; Gordon IO; Nolte AC; Perecman A; Loeb S; Overcash M; Sherman JD
    Eur Urol; 2023 May; 83(5):463-471. PubMed ID: 36635108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The urologist's learning curve of "in-bore" magnetic resonance-guided prostate biopsy.
    Rosenzweig B; Drori T; Raz O; Goldinger G; Shlomai G; Zilberman DE; Shechtman M; Ramon J; Dotan ZA; Portnoy O
    BMC Urol; 2021 Dec; 21(1):169. PubMed ID: 34872545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Role of Multiparametric MRI and MRI Targeted Biopsies for Prostate Cancer Diagnosis in Germany: A Nationwide Survey.
    Saar M; Linxweiler J; Borkowetz A; Fussek S; Urbanova K; Bellut L; Kristiansen G; Wullich B;
    Urol Int; 2020; 104(9-10):731-740. PubMed ID: 32640460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
    Christidis D; McGrath S; Leaney B; O'Sullivan R; Lawrentschuk N
    Urology; 2018 Jan; 111():136-138. PubMed ID: 28823635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial Intelligence - Changing the Field of Prostate Cancer?
    Rohan P; O'Reilly MK; Nason GJ
    Ir Med J; 2020 Mar; 113(3):45. PubMed ID: 32815705
    [No Abstract]   [Full Text] [Related]  

  • 27. Research hotspots of prostate cancer at the international conferences on urology in 2022.
    Yi J; Li J; Xie L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):178-184. PubMed ID: 37283102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
    Fulgham PF; Rukstalis DB; Turkbey IB; Rubenstein JN; Taneja S; Carroll PR; Pinto PA; Bjurlin MA; Eggener S
    J Urol; 2017 Oct; 198(4):832-838. PubMed ID: 28483574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current practice and access to prostate MR imaging in France.
    Renard-Penna R; Rouvière O; Puech P; Borgogno C; Abbas L; Roy C; Claudon M; Correas JM; Cormier L; Ploussard G; Mejean A; Tezenas-du-Montcel S; Rozet F
    Diagn Interv Imaging; 2016 Nov; 97(11):1125-1129. PubMed ID: 27451262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI.
    Kasivisvanathan V; Ambrosi A; Giganti F; Chau E; Kirkham A; Punwani S; Allen C; Emberton M; Moore CM
    Eur Urol; 2019 Jan; 75(1):203-204. PubMed ID: 30327275
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy.
    Lenfant L; Beitone C; Troccaz J; Beaugerie A; Rouprêt M; Seisen T; Renard-Penna R; Voros S; Mozer PC
    Eur Urol Oncol; 2024 Jun; 7(3):430-437. PubMed ID: 37599199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
    de Rooij M; Israël B; Tummers M; Ahmed HU; Barrett T; Giganti F; Hamm B; Løgager V; Padhani A; Panebianco V; Puech P; Richenberg J; Rouvière O; Salomon G; Schoots I; Veltman J; Villeirs G; Walz J; Barentsz JO
    Eur Radiol; 2020 Oct; 30(10):5404-5416. PubMed ID: 32424596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop.
    Setia S; Feng C; Coogan C; Vourganti S; Abern M
    Urology; 2019 Dec; 134():51-55. PubMed ID: 31542464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?
    Walton Diaz A; Hoang AN; Turkbey B; Hong CW; Truong H; Sterling T; Rais-Bahrami S; Siddiqui MM; Stamatakis L; Vourganti S; Nix J; Logan J; Harris C; Weintraub M; Chua C; Merino MJ; Choyke P; Wood BJ; Pinto PA
    J Urol; 2013 Dec; 190(6):2020-2025. PubMed ID: 23792130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).
    Ettala O; Jambor I; Montoya Perez I; Seppänen M; Kaipia A; Seikkula H; Syvänen KT; Taimen P; Verho J; Steiner A; Saunavaara J; Saukko E; Löyttyniemi E; Sjoberg DD; Vickers A; Aronen H; Boström P
    BMJ Open; 2022 Apr; 12(4):e053118. PubMed ID: 35428621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
    Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
    Urology; 2018 Jul; 117():57-63. PubMed ID: 29679601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?
    Williams C; Ahdoot M; Daneshvar MA; Hague C; Wilbur AR; Gomella PT; Shih J; Khondakar N; Yerram N; Mehralivand S; Gurram S; Siddiqui M; Pinsky P; Parnes H; Merino M; Wood B; Turkbey B; Pinto PA
    J Urol; 2022 Jan; 207(1):95-107. PubMed ID: 34433302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation appears as high Prostate Imaging-Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy.
    Rourke E; Sunnapwar A; Mais D; Kukkar V; DiGiovanni J; Kaushik D; Liss MA
    Investig Clin Urol; 2019 Sep; 60(5):388-395. PubMed ID: 31501802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Fascelli et al: Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population (Urology 2016;88:125-134).
    Sertkaya Z
    Urology; 2016 Sep; 95():223. PubMed ID: 27112511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.